gabapentin
Generic: gabapentin
Labeler: pd-rx pharmaceuticals, inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
pd-rx pharmaceuticals, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
43063-673
Product ID
43063-673_36c0c1ca-8073-9d37-e063-6294a90a824f
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA090858
Listing Expiration
2026-12-31
Marketing Start
2011-01-29
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
43063673
Hyphenated Format
43063-673
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA090858 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 30 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-30)
- 45 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-45)
- 60 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-60)
- 90 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-90)
Packages (4)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "36c0c1ca-8073-9d37-e063-6294a90a824f", "openfda": {"nui": ["N0000008486"], "upc": ["0343063673607"], "unii": ["6CW7F3G59X"], "rxcui": ["310431"], "spl_set_id": ["330ddc5d-c67c-33dc-e054-00144ff88e88"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["PD-Rx Pharmaceuticals, Inc."]}, "finished": true, "packaging": [{"sample": false, "description": "30 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-30)", "package_ndc": "43063-673-30", "marketing_start_date": "20201005"}, {"sample": false, "description": "45 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-45)", "package_ndc": "43063-673-45", "marketing_start_date": "20201005"}, {"sample": false, "description": "60 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-60)", "package_ndc": "43063-673-60", "marketing_start_date": "20201005"}, {"sample": false, "description": "90 CAPSULE in 1 BOTTLE, PLASTIC (43063-673-90)", "package_ndc": "43063-673-90", "marketing_start_date": "20201005"}], "brand_name": "Gabapentin", "product_id": "43063-673_36c0c1ca-8073-9d37-e063-6294a90a824f", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "43063-673", "generic_name": "Gabapentin", "labeler_name": "PD-Rx Pharmaceuticals, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA090858", "marketing_category": "ANDA", "marketing_start_date": "20110129", "listing_expiration_date": "20261231"}